Register Now
Course Information

Join us at Clinical Management of Myeloid Malignancies: The Coming of Age of Targeted Therapies

Plan to attend the complimentary lunch symposium that provides an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic and therapeutic management of patients with MDS, AML, myeloid malignancies, aplastic anemia and other bone marrow failure entities. The overall goal of the program is to bring together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations. The program brings leaders in disease research and clinical practice together to explore solutions to improve the care of patients.

By attending, you will be able to:

  • Formulate appropriate evaluation and management strategies for patients with aplastic anemia and other bone marrow failure conditions.
  • Describe genomic-based approaches to the management of patients with acute myeloid leukemia and high-risk myelodysplastic syndromes.
  • Summarize changes in the treatment landscape for patients with low-risk myelodysplastic syndromes.
  • List the pharmacologic profiles, efficacy and side effect data, and indications for recently FDA-approved pharmaceuticals and summarize their use in clinical practice.
  • Diagnose clonal hematopoiesis of indeterminate potential and select treatment options for these patients.
  • Present an in-depth review of myeloproliferative neoplasms, risk stratification, prognostic implications, and treatment options.
  • Identify the indications and the pros and cons of different strategies for bone marrow transplant in patients with myeloid malignancies.

Who Should Attend?

The satellite symposium is designed for an international audience including medical oncologists, hematologists, clinical and translational researchers, and other physicians and allied health care professionals treating patients with MDS and other bone marrow failure diseases. In addition, members of patient advocacy groups will benefit from this program.

This is a Satellite Symposium organized by the Cleveland Clinic Taussig Cancer Institute Leukemia Program and Aplastic Anemia & MDS International Foundation, preceding the 61st ASH Annual Meeting.